FAH and digestive system neoplasm: For example, it would be valuable to evaluate the function of encapsulated iPS-H/SCs aggregates in a liver drug failure model (i.e. CCl4 treated animals24) or in a genetic model (i.e. with fumarylacetoacetate hydrolase (FAH) gene58).